Lene
Lene Aassveen, Oslo NO
Patent application number | Description | Published |
---|---|---|
20080234503 | Purification of Mupirocin - A method for purification of the antibiotic mupirocin (pseudomonic acid A) which comprises: a) Causing or allowing precipitation of mupirocin from an aqueous solution thereof; b) Recovering the precipitate; c) Dissolving the recovered precipitate in an organic solvent. | 09-25-2008 |
20090240071 | PREPARATION AND PURIFICATION OF MUPIROCIN CALCIUM - The present invention relates to methods for the preparation and purification of mupirocin calcium. The process comprises adsorbing mupirocin to a hydrophobic adsorbent resin, exposing the bound mupirocin to a calcium-containing solution, washing impurities from the resin and eluting purified mupirocin calcium from the resin. | 09-24-2009 |
20090275739 | Purification of Glycopeptides - A novel and improved method for purification of glycopeptides, especially glycopeptide antibiotics. The method comprises contacting a solution of the glycopeptide to an ion exchange chromatography material. The product of this method has a surprisingly high purity. | 11-05-2009 |
20140371423 | METHOD FOR PURIFICATION OF MICAFUNGIN - The present invention relates to a method for the purification of Micafungin. | 12-18-2014 |
Lene Axelsen, Brondby DK
Patent application number | Description | Published |
---|---|---|
20130157953 | TREATMENT OF CARDIAC CONDITIONS - The invention relates to the treatment of cardiac dysfunction. In particular, certain compounds, believed to be glucagon-GLP-1 dual agonist compounds, exert a positive inotropic effect while preserving the energy balance of the heart, and so may be superior to known inotropic agents such as dobutamine, norepinephrine and glucagon. | 06-20-2013 |
Lene Bøjlesen, Viby J DK
Patent application number | Description | Published |
---|---|---|
20120189737 | DRINKABLE ACIDIFIED DAIRY PRODUCT BASED ON ACID WHEY AND A PROCESS OF PREPARING IT - The present invention relates to a process for the manufacturing of a drinkable acidified dairy product based on acid whey without coagulum formation after acidification, said drinkable dairy product has a casein:whey protein ratio of from 0.5:99.5 to 12:88 (w/w), wherein the process involve the direct mixing of all ingredients before acidified. In addition, the invention provides a drinkable acidified dairy product obtainable by the present process with low casein content. While having the same flavour and organoleptic characteristics as traditional drinking yoghurt, it has a different protein structure and a different composition with regard to the content of casein and whey proteins. | 07-26-2012 |
Lene Britze, Kokkedal DK
Patent application number | Description | Published |
---|---|---|
20150202131 | HIGH PROTECTION WATER-RESISTANT SUNSCREEN COMPOSITION - Thus, one aspect of the invention relates to a sunscreen composition comprising at least one sunscreen agent, at least one film forming polymer, and at least one solvent, wherein said film forming polymer is present in an amount of less than 2.0% (w/w). Another aspect of the present invention relates to a process for the manufacture of a sunscreen composition comprising the steps of i) providing at least one solvent, at least one film forming polymer in an amount of less than 2.0% (w/w), and at least one sunscreen agent, ii) admixing the components of step i) to provide a sunscreen composition. | 07-23-2015 |
Lene Haudrum, Taastrup DK
Patent application number | Description | Published |
---|---|---|
20130208930 | HEARING AID SYSTEM AND METHOD OF FITTING A HEARING AID SYSTEM - A hearing aid system ( | 08-15-2013 |
Lene Hørlyck, Birkerod DK
Patent application number | Description | Published |
---|---|---|
20110265557 | Method of Quality Control Testing a Factor XIII Containing Sample - The invention relates to a method of quality control testing a Factor XIII (FXIII) containing sample which comprises the step of detecting the presence of and/or measuring the concentration of pre-activated FXIII (FXIIIao) in said sample and to a quality control kit for determining the quality of a Factor XIII (FXIII) containing sample. Preferably, an anion-exchange chromatographic column is used, as well as the fluorescent substrate Abz-NE (Cad-Dnp) EQVS PLTLLK-OH. | 11-03-2011 |
Lene Jensen, Malov DK
Patent application number | Description | Published |
---|---|---|
20100099710 | SRC FAMILY KINASE INHIBITORS - The invention relates to compounds of general formula (I) wherein X, A, R | 04-22-2010 |
Lene Martin, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20100241606 | COMPUTERIZED IDENTIFICATION OF NORMAL AND ABNORMAL DIURNAL CORTISOL SECRETION PATTERNS AND LEVELS OF TESTOSTERONE FROM HUMAN SALIVA SAMPLES - Normal and abnormal diurnal cortisol secretion patterns are identified from human saliva samples by an in vitro method. First and second saliva samples are taken from one human individual at first and second predetermined times during the same day. A first cortisol concentration is determined in the first saliva sample, and a second cortisol concentration is determined in the second saliva sample. An abnormal secretion pattern is then compared to a normal secretion pattern with the help of a fuzzy logic algorithm. A function of the hypothalamic-pituitary-adrenal (HPA) axis is then determined for the human individual. Optionally, a testosterone level is determined from one of the samples and is used in combination with the cortisol concentrations to provide a redefined determination. | 09-23-2010 |
Lene Pedersen, Kobenhavn DK
Patent application number | Description | Published |
---|---|---|
20090264300 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES - Disclosed is a method for obtaining a bifunctional complex comprising a molecule linked to a single stranded identifier oligonucleotide, wherein a nascent bifunctional complex comprising a chemical reaction site and a priming site for enzymatic addition of a tag is a) reacted at the chemical reaction site with one or more reactants, and b) reacted enzymatically at the priming site with one or more tag(s) identifying the reactant(s). | 10-22-2009 |
Lene Vestergaard Hau, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100012827 | METHODS, SYSTEMS, AND APPARATUS FOR STORAGE, TRANSFER AND/OR CONTROL OF INFORMATION VIA MATTER WAVE DYNAMICS - Methods, systems and apparatus for generating atomic traps, and for storing, controlling and transferring information between first and second spatially separated phase-coherent objects, or using a single phase-coherent object. For plural objects, both phase-coherent objects have a macroscopic occupation of a particular quantum state by identical bosons or identical BCS-paired fermions. The information may be optical information, and the phase-coherent object(s) may be Bose-Einstein condensates, superfluids, or superconductors. The information is stored in the first phase-coherent object at a first storage time and recovered from the second phase-coherent object, or the same first phase-coherent object, at a second revival time. In one example, an integrated silicon wafer-based optical buffer includes an electrolytic atom source to provide the phase-coherent object(s), a nanoscale atomic trap for the phase-coherent object(s), and semiconductor-based optical sources to cool the phase-coherent object(s) and provide coupling fields for storage and transfer of optical information. | 01-21-2010 |